Advanced searches left 3/3
Search only database of 12 mil and more summaries

ALKEM LABORATORIES

Summarized by PlexPage
Last Updated: 13 January 2022

* If you want to update the article please login/register

General | Latest Info

ALKEM LABORATORIES

TypePublic
Traded asBSE : 539523 NSE : ALKEM
IndustryPharmaceuticals
Founded1973
FounderSamprada Singh
HeadquartersMumbai , Maharashtra , India
Key peopleBasudeo Narayan Singh (Executive Chairman) Sandeep Singh (MD)
ProductsPharmaceuticals , generic drugs , over-the-counter drugs , vaccines , diagnostics , contact lenses , animal health
Revenue84,485 million (US$1.1 billion) (2020)
Operating income12,597 million (US$170 million) (2020)
Net income11,270 million (US$150 million) (2020)
Total assets99,433 million (US$1.3 billion) (2020)
Total equity63,089 million (US$840 million) (2020)
Number of employees14,331 (2020)
Websitewww .alkemlabs .com
Facebookalkemlabsltd

Alkem Laboratories Ltd. , Incorporated in the year 1973, is a Large Cap firm operating in the Pharmaceuticals market. Alkem's products are extensively prescribed by the clinical career in India and some of the Indian Pharma market's leading brands are Alkem brand names. After considerable study, Alkem extends its undertaking in the worldwide health food market. For the quarter finished 30-09-2021, the firm has reported a Consolidated Total Income of Rs 2841. 95 Crore, up 2. 30 % from last quarter's Total Income of Rs 2778. 01 Crore and up 18. 50 % from last year's same quarter's Total Income of Rs 2398. 34 Crore.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

Related video

14 August 2021Is Alkem Laboratories a Hidden FMCG Stock? Analysis Video #alkem

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

ALKEM LABORATORIES (latest news)

Alkem Laboratories Limited shareholders may be concerned after seeing the share cost drop 10% in the last quarter. India presently has about 77 mn diabetes patients, the second highest on the planet.

A diabetic person foot ulcer is just one of the most considerable and damaging problems of diabetes and is defined as a foot impacted by ulceration that is related to neuropathy and/or outer arterial disease of the reduced limb in an individual with diabetic issues. Roughly, 12-15% with diabetes experience DFU at the very least once in a life time. The threat of foot ulceration and limb amputation enhances with age and the period of diabetic issues. Alkem has teamed up with Rokit Healthcare Inc. To market the technology in India to aid minimize amputation amongst DFU patients considering the negative effect of amputation on a client's lifestyle and the involved financial problem on the healthcare system.

The complainant is taking legal action against for patent infringement and looks for a long-term order of Alkems activity before expiration of the license as well as declaratory judgment concerning the infringement of the license. Typically talking, the lengthy term returns will provide you a far better idea of service quality than short periods can. By contrasting revenues per share and share rate adjustments over time, we can obtain a feel for just how investor perspectives to a business have changed gradually.

When considering financial investment returns, it is necessary to take into consideration the distinction in between total investor return and share price return. For companies that pay a generous dividend, the TSR is commonly a whole lot greater than the share cost return. It's always interesting to track share rate performance over the longer term. Please note, the marketplace returns priced quote in this article reflect the marketplace weighted typical returns of stocks that presently trade on in exchanges.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo

© All rights reserved
2022 made by Algoritmi Vision Inc.

If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.